Advertisement
Advertisement

Agnes Shanley

UBM Americas

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

Advertisement

Critical FDA Functions Continue as US Government Shutdown Hits the One-Week Mark

December 29, 2018

Core functions and those funded by FY 2018 user fees are continuing, and 59% of the Agency’s staffers are being retained.

Tech Transfer: Tearing Down the Wall

December 02, 2018

Once described as “throwing processes over the wall,” tech transfer is evolving into close collaboration and communication, as potential problems are considered sooner, and new technology is applied. Joseph Szczesiul, director of technical services for UPM Pharmaceuticals, shares best practices.

Multiple Attributes Monitoring: A New Phase in PAT for Biopharmaceuticals

November 15, 2018

By reducing the number of assays needed and allowing product quality attributes to be measured end to end, MAM promises to allow users to gain product and process understanding much sooner than they could in the past, and to ensure quality and safety in a more efficient, streamlined way, throughout the product life cycle.

Mixed Reality Gains a Foothold in the Lab

November 15, 2018

Rather than isolating the user in a virtual world, mixed reality allows contextualized data to be shared in real time, improving assays, standard operating procedures, workflows, and overall tech transfer.

Advertisement

Can Gene Therapy Deliver on its Promise?

November 14, 2018

Improving the manufacturing of gene therapy vectors will be crucial to making advanced treatments accessible to more patients who need them, agreed panelists at the 2018 Galien Forum.

Advertisement
Advertisement
Advertisement
x